New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 20, 2013
11:03 EDTFRAN, AMRN, ARO, EZCH, MWOptions with decreasing implied volatility: FRAN AMRN ARO EZCH MW
News For FRAN;AMRN;ARO;EZCH;MW From The Last 14 Days
Check below for free stories on FRAN;AMRN;ARO;EZCH;MW the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 12, 2014
09:02 EDTAMRNAmarin says FDA office denies appeal of ANCHOR rescission
08:00 EDTMWMen's Wearhouse core strength offset by Jos. A. Bank, says Cowen
Cowen said the strength of the core business at Men's Wearhouse was offset by margin pressure in Jos. A. Bank, which has the potential to continue through the remainder of the year. The firm has lowered its expectations due to the pressure and feels the Street's earnings growth rate expectations for 2015 seem optimistic, though Cowen keeps its Outperform rating and $62 price target on the stock.
September 11, 2014
10:49 EDTMWHigh option volume stocks
Subscribe for More Information
10:20 EDTMWMen's Wearhouse heads lower after initial bounce off lows
Subscribe for More Information
09:57 EDTMWMen's Wearhouse backs EPS reaching at least $5.50 by 2017
Subscribe for More Information
09:19 EDTMWMen's Wearhouse: Sales for Jos. A. Bank will be somewhat lumpy
Subscribe for More Information
September 10, 2014
17:39 EDTMWMen's Wearhouse reports Q2 Jos. A. Bank SSS up 1%, Moores Q2 SSS up 10.2%
17:32 EDTMWMen's Wearhouse reports Q2 adjusted EPS $1.10, consensus $1.06
Subscribe for More Information
15:50 EDTMWNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Restoration Hardware (RH), consensus 64c; Men's Wearhouse (MW), consensus $1.06; Five Below (FIVE), consensus 14c; Sigma Designs (SIGM), consensus (8c); Wet Seal (WTSL), consensus (9c).
15:36 EDTMWMen's Wearhouse September 55 straddle priced for 6.6% move into Q2
14:17 EDTAMRNAmarin says Vascepa SPA rescission appeal on ANCHOR sNDA ongoing
Amarin says it is appealing to a higher level and if appeal is not successful that the company may pursue judicial relief under the First Amendment. Amarin says that the fight over Vascepa's sNDA for a mixed dyslipidemia indication is an "uphill battle," but the company believes patient care would benefit and that the company has valid legal, clinical and regulatory arguments. Information from slides for the company's presentation at the Rodman & Renshaw Global Investment conference.
08:04 EDTFRANFrancesca's jewelery rebound bodes well for outlook, says Wedbush
Subscribe for More Information
06:35 EDTFRANFrancesca's shares a buy following guidance, says Jefferies
Subscribe for More Information
September 9, 2014
09:12 EDTFRANOn The Fly: Pre-market Movers
Subscribe for More Information
07:37 EDTFRANFrancesca's sees FY14 EPS 88c-98c, consensus $1.05
Subscribe for More Information
07:35 EDTFRANFrancesca's sees Q3 EPS 17c-22c, consensus 25c
Sees Q3 revenue $87M-$92M, consensus $92.59M. Sees mid-to low-single digit decrease in SSS.
07:33 EDTFRANFrancesca's reports Q2 EPS 24c, consensus 26c
Subscribe for More Information
06:49 EDTMWMen's Wearhouse September volatility elevated into Q2
Subscribe for More Information
September 8, 2014
15:27 EDTFRANNotable companies reporting before tomorrow's open
Subscribe for More Information
14:23 EDTFRANFrancesca's technical commentary before earnings
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use